KIAA0406 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.998000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.219200E-01
Normal-vs-Stage2
7.549600E-01
Normal-vs-Stage3
4.677900E-02
Normal-vs-Stage4
6.757200E-01
Stage1-vs-Stage2
3.909800E-01
Stage1-vs-Stage3
7.601900E-03
Stage1-vs-Stage4
9.483600E-01
Stage2-vs-Stage3
6.210000E-02
Stage2-vs-Stage4
4.510600E-01
Stage3-vs-Stage4
6.235200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.447600E-01
Normal-vs-AfricanAmerican
9.552600E-01
Normal-vs-Asian
1.523180E-01
Caucasian-vs-AfricanAmerican
8.369600E-01
Caucasian-vs-Asian
7.048000E-02
AfricanAmerican-vs-Asian
8.484200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.172200E-01
Normal-vs-Female
7.855000E-01
Male-vs-Female
7.915200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.557600E-01
Normal-vs-Age(41-60Yrs)
7.523200E-01
Normal-vs-Age(61-80Yrs)
4.925000E-01
Normal-vs-Age(81-100Yrs)
7.893000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.027000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.112780E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.716000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.721740E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.668600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.746600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.367400E-01
Normal-vs-Daily Drinker
8.156200E-01
Normal-vs-Weekly Drinker
7.577000E-01
Normal-vs-Occasional Drinker
6.914600E-01
Normal-vs-Social Drinker
8.500600E-01
Non Drinker-vs-Daily Drinker
4.026800E-01
Non Drinker-vs-Weekly Drinker
6.830000E-01
Non Drinker-vs-Occasional Drinker
4.807900E-02
Non Drinker-vs-Social Drinker
1.298370E-01
Daily Drinker-vs-Weekly Drinker
8.013200E-01
Daily Drinker-vs-Occasional Drinker
2.530600E-01
Daily Drinker-vs-Social Drinker
4.456600E-01
Weekly Drinker-vs-Occasional Drinker
2.411800E-01
Weekly Drinker-vs-Social Drinker
4.035800E-01
Occasional Drinker-vs-Social Drinker
7.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.306200E-01
Normal-vs-Grade 2
7.921200E-01
Normal-vs-Grade 3
8.864000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.935400E-01
Grade 1-vs-Grade 3
2.624200E-01
Grade 1-vs-Grade 4
8.306200E-01
Grade 2-vs-Grade 3
3.638900E-03
Grade 2-vs-Grade 4
7.921200E-01
Grade 3-vs-Grade 4
8.864000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.702600E-01
Normal-vs-NonDiabetic
9.096200E-01
Diabetic-vs-NonDiabetic
8.864600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.151000E-01
Normal-vs-NoPancreatitis
7.503400E-01
Pancreatitis-vs-NoPancreatitis
6.616200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.100400E-01
Normal-vs-N1
7.711800E-01
N0-vs-N1
8.447000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.240400E-01
Normal-vs-TP53-NonMutant
8.461000E-01
TP53-Mutant-vs-TP53-NonMutant
2.161700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
